NM_198253.3(TERT):c.1010A>G (p.Asp337Gly) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 5, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003803518.2

Allele description [Variation Report for NM_198253.3(TERT):c.1010A>G (p.Asp337Gly)]

NM_198253.3(TERT):c.1010A>G (p.Asp337Gly)

Gene:

TERT:telomerase reverse transcriptase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

5p15.33

Genomic location:

Preferred name:

NM_198253.3(TERT):c.1010A>G (p.Asp337Gly)

HGVS:

NC_000005.10:g.1293876T>C
NG_009265.1:g.6172A>G
NM_001193376.3:c.1010A>G
NM_003219.1:c.1010A>G
NM_198253.3:c.1010A>GMANE SELECT
NP_001180305.1:p.Asp337Gly
NP_003210.1:p.Asp337Gly
NP_937983.2:p.Asp337Gly
NP_937983.2:p.Asp337Gly
LRG_343t1:c.1010A>G
LRG_343:g.6172A>G
LRG_343p1:p.Asp337Gly
NC_000005.9:g.1293991T>C
NM_198253.2:c.1010A>G
NR_149162.3:n.1089A>G
NR_149163.3:n.1089A>G

Protein change:

D337G

Molecular consequence:

NM_001193376.3:c.1010A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_003219.1:c.1010A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_198253.3:c.1010A>G - missense variant - [Sequence Ontology: SO:0001583]
NR_149162.3:n.1089A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_149163.3:n.1089A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Dyskeratosis congenita, autosomal dominant 2
Identifiers:: MONDO: MONDO:0013521; MedGen: C3151443; OMIM: 613989

Name:: Idiopathic Pulmonary Fibrosis
Synonyms:: Idiopathic fibrosing alveolitis, chronic form
Identifiers:: MeSH: D054990; MedGen: C1800706

Recent activity

Clear Turn Off Turn On

PREDICTED: Homo sapiens 5'-nucleotidase domain containing 3 (NT5DC3), transcript...
PREDICTED: Homo sapiens 5'-nucleotidase domain containing 3 (NT5DC3), transcript variant X12, misc_RNA
gi|2217289479|ref|XR_944581.3|

Nucleotide
Homo sapiens von Willebrand factor C domain-containing protein 2-like, mRNA (cDN...
Homo sapiens von Willebrand factor C domain-containing protein 2-like, mRNA (cDNA clone MGC:182034 IMAGE:9056859), complete cds
gi|187955073|gb|BC146931.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004592340	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Feb 5, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004592340

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Feb 5, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004592340.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TERT protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with TERT-related conditions. This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 337 of the TERT protein (p.Asp337Gly). This variant is not present in population databases (gnomAD no frequency).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine